Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of diagnostic-test maker Gen-Probe
So what: Bloomberg reported today that Gen-Probe has hired investment bank Morgan Stanley
Now what: As I noted yesterday with InterMune, this kind of news tends to get traders and short-term investors very excited. However, speculation on potential buyouts can often end in disappointment if nothing ever pans out. Longer-term investors would be well-advised to continue focusing on the prospects for Gen-Probe as a stand-alone company and leave the rumors to the traders.
Want to keep up to date on these stocks?